OncoPharm cover image

Clinical Trial Endpoints in Oncology

OncoPharm

00:00

Why Use Surrogate Endpoints

John Bazar asks why trials use surrogates and explains faster results, sequencing, crossover, and disease aggressiveness considerations.

Play episode from 05:12
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app